Therapeutic Asset Ratings

464 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Hidradenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Sweat Gland Cancer	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Malignant Syringoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE NK-Cell Lymphoma, Unclassifiable	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Papillary Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Eccrine Porocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Primary Cutaneous Mucinous Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE T-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Anaplastic Large Cell Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Mycosis Fungoides	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Primary Cutaneous T-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Sezary Syndrome	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Signet Ring Cell Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Cutaneous Adenocystic Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Skin Appendage Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Basosquamous Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Keratoacanthoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Squamous Cell Carcinoma of Unknown Primary	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Sweat Gland Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Trichilemmal Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Vulvar Squamous Cell Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
oh2 Colorectal Carcinoma	Binhui Biopharmaceutical Co., Ltd.	P2	CCC (53)
Olvimulogene Nanivacirepvec Non-Small Cell Lung Carcinoma	Genelux Corporation	P2	CCC (53)
Olvimulogene Nanivacirepvec Non-Small Cell Squamous Lung Carcinoma	Genelux Corporation	P2	CCC (53)

Showing 101 to 125 of 464 assets

PreviousPage 5 of 19Next